Michael F. Mahoney is the Chairman of the Board, President, and Chief Executive Officer at Boston Scientific Corporation, a global leader in the medical device industry. Mahoney joined Boston Scientific in 2012, bringing with him extensive experience in the healthcare sector. Prior to his current role, he served as Worldwide Chairman of the Medical Devices and Diagnostics division at Johnson & Johnson, where he was responsible for overseeing a diverse portfolio of medical technology businesses. Mahoney's leadership and strategic vision have been instrumental in driving Boston Scientific's growth and innovation in the medical device market. Under Mahoney's leadership, Boston Scientific has achieved significant milestones, including the expansion of its product portfolio and the strengthening of its global presence. He has been a driving force behind the company's focus on developing cutting-edge technologies that address unmet medical needs, particularly in the areas of cardiology, urology, and endoscopy. Mahoney's commitment to innovation has led to the successful launch of several groundbreaking products, such as the WATCHMAN FLX™ Left Atrial Appendage Closure Device and the LOTUS Edge™ Aortic Valve System. His strategic initiatives have also resulted in numerous acquisitions and partnerships that have enhanced Boston Scientific's capabilities and market position. As Chairman, President, and CEO, Mahoney plays a pivotal role in shaping Boston Scientific's corporate strategy and fostering a culture of excellence and inclusivity. He is deeply committed to the company's mission of transforming lives through innovative medical solutions and has championed initiatives to promote diversity, equity, and inclusion within the organization. Mahoney's leadership extends beyond the company, as he actively participates in industry associations and serves on the board of directors for several organizations, including AdvaMed and Massachusetts General Hospital. His vision, dedication, and proven track record of success continue to drive Boston Scientific's growth and solidify its position as a leader in the medical device industry.